Selank
Selank is a synthetic analogue of the immunomodulatory peptide tuftsin.
- Vial Size
- 10mg
- Molecular Weight
- 751.86 g/mol
- Half-life
- Short plasma; extended CNS receptor effects
- Latest Lot Purity
- 99.62%
Mechanism of Action
Selank is a synthetic analogue of the immunomodulatory peptide tuftsin. Research models study its anxiolytic, GABAergic, and immunomodulatory profile without the sedative and dependency-associated effects of classical anxiolytics.
Research Context
- GABAergic signalling research
- Anxiolytic-profile study models
- Neuroimmune modulation studies
- Cognitive-resilience research
Thr-Lys-Pro-Arg-Pro-Gly-Pro
Plasma Profile & Protocol
Modelled plasma concentration over time, reconstitution calculator, and a literature-derived research protocol for Selank.
Illustrative Bateman model derived from published half-life and absorption data. For research-context visualisation only.
Solve for syringe units assuming a U-100 insulin syringe. Defaults seeded from the Selank monograph.
U-100 insulin syringe assumed (100 units = 1 mL). For research dosing visualisation only. Verify all dilutions independently.
- Typical Dose
- 250–500 mcg
- Frequency
- 1–3× daily
- Cycle Length
- 2–4 weeks
- Route
- Intranasal or subQ
Note ·Anxiolytic-profile research; intranasal favored in CNS models.
Related Compounds
All compounds →
Semax
Neurotrophic peptide for cognitive and resilience-focused research.
For Research Use Only · This monograph summarises publicly available research literature for educational, in-vitro and laboratory research purposes only. Nexora Labs products are not drugs, food, supplements, or cosmetics, and are not intended to diagnose, treat, cure or prevent any condition.